Shanberge J N, Murato M, Quattrociocchi-Longe T, van Neste L
Am J Clin Pathol. 1987 Feb;87(2):210-7. doi: 10.1093/ajcp/87.2.210.
Neutralization by protamine of the heparin activation of antithrombin III in plasma, in vitro, represents an equilibrium reaction in which by mass action heparin remains complexed only in the presence of an excess of protamine. Loss of this excess through enzymatic breakdown of the free protamine leads to instability of the complexes with liberation of the heparin, reestablishing antithrombin activity. This "heparin rebound" can also be produced by an increase in heparin levels or increased amounts of antithrombin III. These phenomena could occur after extracorporeal bypass procedures by an increase in heparin from whatever source or by added antithrombin III, through transfusions of fresh frozen plasma. A larger excess of protamine does not itself act as an anticoagulant but produces large heparin-protamine complexes that can still activate antithrombin III. Such large complexes, formed in vivo, could possibly block the pulmonary microcirculation and cause the acute pulmonary hypertension that has been reported after protamine infusions.
在体外,鱼精蛋白对血浆中抗凝血酶III的肝素激活作用的中和代表一种平衡反应,根据质量作用定律,只有在存在过量鱼精蛋白的情况下肝素才会保持复合物状态。游离鱼精蛋白的酶促降解导致这种过量的丧失,致使复合物不稳定并释放肝素,从而重新建立抗凝血酶活性。“肝素反跳”也可由肝素水平升高或抗凝血酶III量增加引起。这些现象可能在体外循环手术后发生,原因是无论何种来源的肝素增加或通过输注新鲜冷冻血浆添加抗凝血酶III。过量较多的鱼精蛋白本身并不具有抗凝作用,但会产生仍能激活抗凝血酶III的大型肝素-鱼精蛋白复合物。在体内形成的这种大型复合物可能会阻塞肺微循环,并导致鱼精蛋白输注后报告的急性肺动脉高压。